Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma

New England Journal of Medicine

Volumn 326, Issue 20, 1992, Pages 1301-1308

  Toguchida, Junya ^a   Yamaguchi, Toshikazu ^b   Dayton, Siri H ^a   Beaughamp, Roberta L ^a   Herrera, Guillermo E ^a   Ishizaki, Kanji ^b   Yamamuro, Takao ^b   Meyers, Paul A ^c   Little, John B ^d   Sasaki, Masao S ^b   Weichselbaum, Ralph R ^d,e   Yandell, David W ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; AMINO ACID; CYTOSINE; DNA; GUANINE; PROTEIN P53; THYMINE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CODON; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GERM LINE; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; NONSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; PATIENT INFORMATION; PEDIGREE ANALYSIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SARCOMA; SCHOOL CHILD; TUMOR SUPPRESSOR GENE;

EID: 0026525839     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199205143262001     Document Type: Article

References (35)

1. Knudson A.G. Jr. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 1985; 45:1437-1443
2. Vogel F. Genetics of retinoblastoma. Hum Genet 1979; 52:1-54.
3. Matkin D., Li F.P., Strong L.C., et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250:1233-1238
4. Srivastava S., Zou Z., Pirollo K., Blattner W., Chang E.H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li—Fraumeni syndrome. Nature 1990; 348:747-749
5. Li F.P., Fraumeni J.F. Jr., Mulvihill J.J., et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988; 48:5358-5362
6. Lane D.P., Crawford L.V. T antigen is bound to a host protein in SV40-transformed cells. Nature 1979; 278:261-263
7. Fields S., Jang S.K. Presence of a potent transcription activating sequence in the p53 protein. Science 1990; 249:1046-1049
8. Raycroft L., Wu H., Lozano G. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 1990; 249:1049-1051
9. Iguchi-Ariga S.M.M., Okazaki T., Itani T., Ariga H. Cloning of the p53-dependent origin of cellular DNA replication. Oncogene 1988; 3:509-515
10. Kern S.E., Kinzler K.W., Bruskin A., et al. Identification of p53 as a sequence-specific DNA-binding protein. Science 1991; 252:1708-1711
11. Finlay C.A., Hinds P.W., Levine A.J. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989; 57:1083-1093
12. Baker S.J., Markowitz S., Fearon E.R., Wilson J.K.V., Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990; 249:912-915
13. Masuda H., Miller C., Koeffler H.P., Battifora H., Cline M.J. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A 1987; 84:7716-7719
14. Nigro J.M., Baker S.J., Preisinger A.C., et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989; 342:705-708
15. Ahuja H., Bar-Eli M., Advani S.H., Benchimol S., Cline M.J. Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc Natl Acad Sci U S A 1989; 86:6783-6787
16. Mulligan L.M., Matlashewski G.J., Scrable H.J., Cavenee W.K. Mechanisms of p53 loss in human sarcomas. Proc Natl Acad Sci U S A 1990; 87:5863-5867
17. Tamboli A., Podgor M.J., Horm J.W. The incidence of retinoblastoma in the United States: 1974 through 1985. Arch Ophthalmol 1990; 108:128-132
18. Goorin A.M., Abelson H.T., Frei E. III. Osteosarcoma: fifteen years later. N Engl J Med 1985; 313:1637-1643
19. Crist W.M., Garnsey L., Beltangady M.S., et al. Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. J Clin Oncol 1990; 8:443-452
20. Mowat M., Cheng A., Kimura N., Bernstein A., Benchimol S. Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus. Nature 1985; 314:633-636
21. Hinds P., Finlay C., Levine A.J. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol 1989; 63: 739-46.
22. Soussi T., Caron de Fromentel C., May P. Structural aspects of the p53 protein in relation to gene evolution. Oncogene 1990; 5:945-952
23. Metzger A.K., Sheffield V.C., Duyk G., Daneshvar L., Edwards M.S.B., Cogen P.H. Identification of a germ-line mutation in the p53 gene in a patient with intracranial ependymoma. Proc Natl Acad Sci U S A 1991; 88:7825-7829
24. Kunkel L.M., Smith K.D., Boyer S.H., et al. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 1977; 74:1245-1249
25. Saiki R.K., Scharf S., Faloona F., et al. Enzymatic amplification of betaglobin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230:1350-1354
26. Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5:874-879
27. Yandell D.W., Dryja T.P. Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing. Am J Hum Genet 1989; 45:547-555
28. Matlashewski G.J., Tuck S., Pim D., Lamb P., Schneider J., Crawford L.V. Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 1987; 7:961-963
29. Baker S.J., Preisinger A.C., Jessup J.M., et al. p53 Gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990; 50:7717-7722
30. Milner J., Medcalf E.A. Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell 1991; 65:765-774
31. Kraiss S., Quaiser A., Oren M., Montenarh M. Oligomerization of oncoprotein p53. J Virol 1988; 62:4737-4744
32. Abramson D.H., Ellsworth R.M., Kitchin F.D., Tung G. Second nonocular tumors in retinoblastoma survivors: are they radiation-induced? Ophthalmology 1984; 91:1351-1355
33. Takebe H., Utsunomiya J., eds. Genetics of human tumors in Japan. Gann monograph on cancer research no. 35. Tokyo: Japan Scientific Societies Press, 1988.
34. Tamura G., Kihana T., Nomura K., Terada M., Sugimura T., Hirohashi S. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res 1991; 51:3056-3058
35. Kim J.-H., Takahashi T., Chiba I., et al. Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines. J Natl Cancer Inst 1991; 83:93843.